Senior insider sale
CEO and Chairman at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$7.96M
321.32K shares
What this filing means
ROBINS CHAD M plans to sell 321.32K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $7.96M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001958244-26-000521
DirectorOfficer· CEO and Chairman
Since Jun 2019
321.32K
Shares to sell
$7.96M
Approx. market value
321.32K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
2/7/2018
321.32KTotal acquired321.32K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/7/2018 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 321.32K | — |
| Total | 321.32K | ||
Planned & Completed Dispositions1
NASDPlanned
Units to sell
321.32K
Market value
$7.96M
8/17/2026
Total
Units
321.32K
Value
$7.96M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 321.32K | $7.96M | NASD | Planned |
| Total | 321.32K | $7.96M | ||